Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|Independent Lab Verified|≥98% Purity Guarantee|Shipped Within 24hrs|Research Use Only|International Shipping|North American Made|Free Shipping $149 USD+|
peptide dosing

Leuprolide Dosing & Reconstitution Guide

Complete dosing reference for Leuprolide (Reproductive / Hormonal). Covers reconstitution, dose range, titration schedule, pharmacokinetics, and storage protocols for research use.

Dosing Protocol

Route: Intramuscular (Lupron Depot) or Subcutaneous (Eligard) Frequency: Monthly, every 3 months, every 4 months, or every 6 months depending on formulation Dose Range: Prostate cancer: 7.5 mg monthly, 22.5 mg q3mo, 30 mg q4mo, or 45 mg q6mo. Endometriosis: 3.75 mg monthly or 11.25 mg q3mo for 6 months. CPP: 7.5-15 mg monthly (weight-based).

Timeline & Pharmacokinetics

Onset: 2-4 weeks (testosterone suppression) Half-Life: ~3 hours Steady State: 2-4 weeks (depot formulations) Time to Results: 2-4 weeks for hormonal suppression Washout: 4-12 weeks depending on depot formulation

Storage

Lyophilized: Store at 25 °C (77 °F); excursions permitted to 15-30 °C. Lupron Depot kits may be stored at room temperature. Reconstituted: Use immediately after reconstitution; do not store

Injection Sites

Gluteal muscle (IM for Lupron Depot), Abdomen (SC for Eligard), Upper arm

Safety & Contraindications

Safety: Hot flashes/vasomotor symptoms (most common, up to 55-80% of patients) Bone mineral density loss with prolonged use (limit treatment to 6 months for endometriosis without add-back therapy) Initial testosterone/estrogen flare during first 1-2 weeks: may worsen bone pain or urinary symptoms in prostate cancer (can be prevented by concurrent anti-androgen)

Contraindications: Pregnancy (Category X; may cause fetal harm); Undiagnosed abnormal vaginal bleeding; Hypersensitivity to GnRH, GnRH agonists, or any component of the formulation

Frequently Asked Questions

Explore More

Research Use Only. The information on this page is compiled from published research literature and is provided for educational purposes only. It does not constitute medical advice. All compounds referenced are intended for in vitro research use by qualified laboratories and institutions.

Your Cart

Your cart is empty

Browse our catalog to add research compounds.